INDOUSOther Agricultural Products
Indo US Bio Tech Ltd — Cash Flow Statement
₹98.21
-0.51%
Indo US Bio Tech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Interest Received Cfi | 0.07 Cr | 0.01 Cr | 0.00 | 25635.00 | — |
| Net PPE Purchase And Sale | -0.86 Cr | -2.61 Cr | -1.82 Cr | -3.97 Cr | — |
| Purchase Of PPE | -0.86 Cr | -2.61 Cr | -1.82 Cr | -3.97 Cr | — |
| Operating Cash Flow | 1.42 Cr | 2.22 Cr | 0.53 Cr | 2.70 Cr | — |
| Taxes Refund Paid | -0.35 Cr | -0.31 Cr | -0.31 Cr | -0.39 Cr | — |
| Change In Working Capital | -17.76 Cr | -8.52 Cr | -8.56 Cr | -3.86 Cr | — |
| Change In Other Current Liabilities | 0.37 Cr | 0.77 Cr | -0.07 Cr | -0.28 Cr | — |
| Change In Other Current Assets | 0.47 Cr | 6.79 Cr | 0.03 Cr | 0.47 Cr | — |
| Change In Payable | -3.23 Cr | 2.99 Cr | -0.76 Cr | 3.31 Cr | — |
| Change In Inventory | -18.95 Cr | -24.82 Cr | -3.56 Cr | -11.48 Cr | — |
| Change In Receivables | 3.58 Cr | 5.76 Cr | -4.20 Cr | 4.16 Cr | — |
| Other Non Cash Items | 1.42 Cr | 1.51 Cr | 1.18 Cr | 1.19 Cr | — |
| Provisionand Write Offof Assets | 0.47 Cr | -0.06 Cr | 0.00 | — | — |
| Depreciation And Amortization | 1.10 Cr | 0.80 Cr | 0.83 Cr | 0.45 Cr | — |
| Depreciation | 1.10 Cr | 0.80 Cr | 0.83 Cr | 0.45 Cr | — |
| Pension And Employee Benefit Expense | 63000.00 | -10000.00 | 68320.00 | 57441.00 | — |
| Net Income From Continuing Operations | 16.53 Cr | 8.79 Cr | 7.39 Cr | 5.31 Cr | — |
| Free Cash Flow | 0.56 Cr | -0.39 Cr | -1.30 Cr | -1.26 Cr | — |
| Issuance Of Debt | 0.51 Cr | 2.73 Cr | 0.79 Cr | 1.27 Cr | — |
| Capital Expenditure | -0.86 Cr | -2.61 Cr | -1.82 Cr | -3.97 Cr | — |
| End Cash Position | 0.25 Cr | 1.10 Cr | 0.19 Cr | 0.05 Cr | — |
| Beginning Cash Position | 1.10 Cr | 0.19 Cr | 0.05 Cr | 0.13 Cr | — |
| Changes In Cash | -0.85 Cr | 0.91 Cr | 0.14 Cr | -0.09 Cr | — |
| Financing Cash Flow | -1.48 Cr | 1.22 Cr | 6.29 Cr | 2.65 Cr | — |
| Net Other Financing Charges | -1000.00 | — | -1000.00 | 8252.00 | 4643.00 |
| Interest Paid Cff | -1.49 Cr | -1.51 Cr | -1.18 Cr | -1.18 Cr | — |
| Cash Dividends Paid | -0.50 Cr | — | — | -0.15 Cr | — |
| Net Issuance Payments Of Debt | 0.51 Cr | 2.73 Cr | -0.90 Cr | 1.27 Cr | — |
| Net Short Term Debt Issuance | 0.38 Cr | 1.63 Cr | 0.79 Cr | 0.99 Cr | — |
| Short Term Debt Issuance | 0.38 Cr | 1.63 Cr | 0.79 Cr | 0.99 Cr | — |
| Net Long Term Debt Issuance | 0.13 Cr | 1.10 Cr | -1.69 Cr | 0.28 Cr | — |
| Long Term Debt Issuance | 0.13 Cr | 1.10 Cr | — | 0.28 Cr | 2.60 Cr |
| Investing Cash Flow | -0.79 Cr | -2.53 Cr | -6.67 Cr | -5.44 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | -1.00 | 1.00 | -99000.00 | -1.00 |
| Net Common Stock Issuance | — | 0.00 | 8.38 Cr | 2.71 Cr | 0.00 |
| Common Stock Issuance | — | 0.00 | 8.38 Cr | 2.71 Cr | 0.00 |
| Net Other Investing Changes | — | 0.07 Cr | 0.12 Cr | — | -2.00 |
| Net Investment Purchase And Sale | — | 0.00 | 99000.00 | — | — |
| Sale Of Investment | — | 0.00 | 99000.00 | — | — |
| Change In Prepaid Assets | — | -582.00 | -70206.00 | — | — |
| Gain Loss On Investment Securities | — | 43401.00 | — | — | 0.01 Cr |
| Issuance Of Capital Stock | — | 0.00 | 8.38 Cr | 2.71 Cr | 0.00 |
| Repayment Of Debt | — | — | -1.69 Cr | — | — |
| Long Term Debt Payments | — | — | -1.69 Cr | — | — |
| Common Stock Dividend Paid | — | — | — | -0.16 Cr | 0.00 |
| Sale Of PPE | — | — | — | 0.00 | 0.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Indo US Bio Tech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.